Atlas Trials

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

Clinical trial NCT01049685 · UNKNOWN

Trial details

NCT number
NCT01049685
Sponsor
UPECLIN HC FM Botucatu Unesp
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infections
Start date
2006-08-01
Primary completion
2009-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.